FC
MRNA icon

Fairscale Capital’s Moderna MRNA Stock Holding History

Fairscale Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$980 Hold
14
– – ﹤0.01% 412
2026
Q1 		$711 Hold
14
– – ﹤0.01% 415
2025
Q4 		$413 Hold
14
– – ﹤0.01% 412
2025
Q3 		$362 Hold
14
– – ﹤0.01% 432
2025
Q2 		$414 Hold
14
– – ﹤0.01% 430
2025
Q1 		$397 Hold
14
– – ﹤0.01% 339
2024
Q4 		$582 Hold
14
– – ﹤0.01% 342
2024
Q3 		$936 Hold
14
– – ﹤0.01% 326
2024
Q2 		$1.75K Buy
+14
New +$1.77K ﹤0.01% 314

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fairscale Capital's MRNA Position: Q2 2026 in Review

Fairscale Capital held its Moderna (MRNA) position steady in Q2 2026 at 14 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Fairscale Capital first reported a position in MRNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.75K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fairscale Capital held 14 shares of Moderna worth $980 as of Q2 2026.
  • Fairscale Capital left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Fairscale Capital's portfolio in Q2 2026, its #412 holding.
  • Fairscale Capital first reported a position in Moderna in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Moderna position peaked at $1.75K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.